Catalog |
name |
Description |
price |
R-R-2851 |
Glucagon-like peptide 1 (1-37), human TFA |
Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor. |
price> |
R-R-2852 |
Crotedumab CAS No.1452387-69-7 |
Crotedumab (REGN1193)/CAS No.1452387-69-7 is a fully human IgG4 monoclonal antibody that binds and inhibits glucagon receptor (GCGR), with a KD of 0.1 nM. Crotedumab can be used for the research of diabetes. |
price> |
R-R-2853 |
VU0453379 CAS No.1638646-27-1 |
VU0453379/CAS No.1638646-27-1 is a highly selective and central nervous system (CNS) penetrant positive allosteric modulator (PAM) of glucagon-like peptide-1R (GLP-1R) with an EC50 of 1.3 μM. |
price> |
R-R-2854 |
GLP-1R agonist 4 CAS No.2401894-26-4 |
GLP-1R agonist 4/CAS No.2401894-26-4 is a potent agonist of GLP-1R. Glucagon-like peptide-1 (GLP-1) is an intestinal hypoglycemic hormone secreted by L-cells in the lower gastrointestinal tract. GLP-1R agonist 4 has the potential for the research of diabetes (extracted from patent WO2019239319A1, compound 96). |
price> |
R-R-2855 |
Exendin (5-39) CAS No.196109-27-0 |
Exendin (5-39)/CAS No.196109-27-0 is a potent glucagon-like peptide 1 (GLP-1) receptor antagonist. Exendin (5-39) improves memory impairment in β-amyloid protein-treated rats. |
price> |
R-R-2856 |
HAEGTFTSD CAS No.926018-45-3 |
HAEGTFTSD/CAS No.926018-45-3 is a 9-residue peptide of human GLP-1 peptide or GLP-1(7-36), amide (HY-P0054A). GLP-1(7-36), amide is a physiological incretin hormone that stimulates insulin secretionin a glucose-dependant manner. |
price> |
R-R-2857 |
HAEGTFTSDVS CAS No.864915-61-7 |
HAEGTFTSDVS/CAS No.864915-61-7 is the first N-terminal 1-11 residues of GLP-1 peptide. |
price> |
R-R-2858 |
GLP-1R agonist 3 CAS No.2428640-18-8 |
GLP-1R agonist 3/CAS No.2428640-18-8 is a potent agonist of GLP-1R. GLP-1R agonist 3 is a thickened imidazole derivative compound. Glucagon-like peptide-1 (GLP-1) is an intestinal hypoglycemic hormone secreted by L-cells in the lower gastrointestinal tract. GLP-1R agonist 3 has the potential for the research of diabetes (extracted from patent WO2021197464A1, compound 1). |
price> |
R-R-2859 |
Glucagon receptor antagonists-1 CAS No.503559-84-0 |
Glucagon receptor antagonists-1/CAS No.503559-84-0 is a highly potent glucagon receptor antagonist. |
price> |
R-R-2860 |
GCGR antagonist 2 CAS No.280134-25-0 |
GCGR antagonist 2/CAS No.280134-25-0, a Furan-2-carbohydrazide, is an orally active glucagon receptor antagonist. GCGR antagonist 2 binds to hGluR with an Kd value of 2.3 nM, and inhibits rat receptor with an IC50 value of 0.43 nM. GCGR antagonist 2 inhibits glucagon-stimulated glycogenolysis. |
price> |